Clinical Trial Update: Effectiveness Assessment of Riluzole in the Prevention of Oxaliplatin-induced Peripheral Neuropathy. [Phase 2]

View source ↗

Summary

A Phase 2 trial evaluating riluzole to prevent oxaliplatin-induced peripheral neuropathy has been suspended.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Peripheral Neuropathy
• Oxaliplatin-induced Peripheral Neuropathy

Drugs mentioned

• Riluzole (riluzole)

Snippet

Sponsor: UNICANCER | Conditions: Oxaliplatin-induced Peripheral Neuropathy | Phase 2 | Status: SUSPENDED